Cristina Montane | Acaf

Cristina Montane, , Acaf


Cristina Montané, linked to patient associations in which she has worked as a volunteer for more than twenty years. She completed the Postgraduate Course in Patient Advocacy at the UIC and the UCM. She is a board member of the Catalan Patient Advisory Council, Citizen Participation Director of the Spanish Patients´ Forum (FEP), Territorial Coordinator and Patient Advocate of ACAF - Association of People Affected by Fibromyalgia and other Central Sensitization Syndromes of Catalonia, President of the FM-SFC-SQM Family Platform, and Member of the Management Committee of the Patient Experience Observatory of Hospital Clinic Barcelona.

Appearances:



Day 1 - Wednesday 23 October @ 11:30

Working Group 5: Enhancing Patient Involvement in HTAs: Practical Strategies for Stakeholder Collaboration

This working group aims to encourage collaboration among stakeholders in the HTA process to improve patient outcomes through enhanced engagement strategies. We will explore key issues surrounding patient involvement in HTAs, with a focus on how pharmaceutical companies can actively contribute to this critical activity.

 

Key discussion areas:

  • Implications of the new HTA Regulation in the EU, effective January 2025, and how they affect patient participation
  • Best practices and ethical considerations in partnerships between pharmaceutical companies and patient advocacy organizations
  • Strategies for ensuring that patients receive clear and understandable information about pharmaceutical products during the HTA process
  • Patient training programs to enhance their participation in HTAs while maintaining ethical boundaries

If you are a stakeholder in the healthcare ecosystem, we invite you to contribute your perspectives and engage in this crucial conversation.

Session led by: alira-health
last published: 13/Oct/24 14:15 GMT

back to speakers